Table 2.
Multiple-regression analysis of clinical, molecular, and biochemical features of IPAH patients.
PGC-1α | 6 MWT | Age | PAP | CI | PVR | CYTC | SOD | TAS | GPX | PaO2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PGC-1α | 0.15585 | 0.03470 | 0.00041 | 0.04289 | 0.00625 | 0.00012 | 0.00277 | 0.00206 | 0.00010 | 0.00618 | P values | |
6 MWT | 0.15585 | 0.00451 | 0.07089 | 0.70377 | 0.55674 | 0.06251 | 0.12445 | 0.01532 | 0.09516 | 0.01279 | ||
Age | 0.03470 | 0.00451 | 0.04786 | 0.35841 | 0.31914 | 0.03581 | 0.04786 | 0.03317 | 0.01683 | 0.01097 | ||
PAP | 0.00041 | 0.07089 | 0.04786 | 0.00791 | 0.00824 | 0.00000 | 0.00033 | 0.00136 | 0.00095 | 0.00705 | ||
CI | 0.04289 | 0.70377 | 0.35841 | 0.00791 | 0.00053 | 0.01155 | 0.01412 | 0.26858 | 0.10484 | 0.06642 | ||
PVR | 0.00625 | 0.55674 | 0.31914 | 0.00824 | 0.00053 | 0.00136 | 0.04461 | 0.05484 | 0.01025 | 0.07415 | ||
CYTC | 0.00012 | 0.06251 | 0.03581 | 0.00000 | 0.01155 | 0.00136 | 0.00136 | 0.00015 | 0.00008 | 0.00209 | ||
SOD | 0.00277 | 0.12445 | 0.04786 | 0.00033 | 0.01412 | 0.04461 | 0.00136 | 0.01391 | 0.00736 | 0.00038 | ||
TAS | 0.00206 | 0.01532 | 0.03317 | 0.00136 | 0.26858 | 0.05484 | 0.00015 | 0.01391 | 0.00033 | 0.00401 | ||
GPX | 0.00010 | 0.09516 | 0.01683 | 0.00095 | 0.10484 | 0.01025 | 0.00008 | 0.00736 | 0.00033 | 0.00554 | ||
PaO2 | 0.00618 | 0.01279 | 0.01097 | 0.00705 | 0.06642 | 0.07415 | 0.00209 | 0.00038 | 0.00401 | 0.00554 | ||
| ||||||||||||
PGC-1α | 0.43663 | −0.61973 | −0.87326 | 0.60071 | −0.75354 | 0.92960 | 0.78171 | 0.79579 | 0.95073 | 0.73852 | Correlation coefficients | |
6 MWT | 0.43663 | −0.75524 | −0.53846 | 0.12281 | −0.18881 | 0.55245 | 0.46853 | 0.67832 | 0.50350 | 0.69123 | ||
Age | −0.61973 | −0.75524 | 0.58042 | −0.29123 | 0.31469 | −0.60839 | −0.58042 | −0.61538 | −0.67133 | −0.70176 | ||
PAP | −0.87326 | −0.53846 | 0.58042 | −0.72281 | 0.72028 | −0.94406 | −0.86014 | −0.81119 | −0.82517 | −0.72983 | ||
CI | 0.60071 | 0.12281 | −0.29123 | −0.72281 | −0.84562 | 0.69825 | 0.68421 | 0.34737 | 0.49123 | 0.54577 | ||
PVR | −0.75354 | −0.18881 | 0.31469 | 0.72028 | −0.84562 | −0.81119 | −0.58741 | −0.56643 | −0.70629 | −0.53334 | ||
CYTC | 0.92960 | 0.55245 | −0.60839 | −0.94406 | 0.69825 | −0.81119 | 0.81119 | 0.88112 | 0.89510 | 0.79299 | ||
SOD | 0.78171 | 0.46853 | −0.58042 | −0.86014 | 0.68421 | −0.58741 | 0.81119 | 0.68531 | 0.72727 | 0.85615 | ||
TAS | 0.79579 | 0.67832 | −0.61538 | −0.81119 | 0.34737 | −0.56643 | 0.88112 | 0.68531 | 0.86014 | 0.76141 | ||
GPX | 0.95073 | 0.50350 | −0.67133 | −0.82517 | 0.49123 | −0.70629 | 0.89510 | 0.72727 | 0.86014 | 0.74386 | ||
PaO2 | 0.73852 | 0.69123 | −0.70176 | −0.72983 | 0.54577 | −0.53334 | 0.79299 | 0.85615 | 0.76141 | 0.74386 |
PaO2: partial pressure of oxygen in arterial blood, 6 MWT: 6-minute walk test, PAP: pulmonary arterial pressure, CI: cardiac index, PVR: pulmonary vascular resistance, VR: vasoreactivity, PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-α, RE: relative mRNA expression, CYTC: cytochrome c, SOD: superoxide dismutase, TAS: total antioxidant status, GPX: glutathione peroxidase.